Accuray Retires Remaining 3.75% Convertible Debt Read more about Accuray Retires Remaining 3.75% Convertible Debt
TomoTherapy® System Provides Favorable Cosmetic Outcomes Without Compromising Efficacy in Low-Risk Breast Cancer Patients Read more about TomoTherapy® System Provides Favorable Cosmetic Outcomes Without Compromising Efficacy in Low-Risk Breast Cancer Patients
Accuray Products Continue to Receive Highest Composite User Satisfaction Ratings in Latest MD Buyline Report Read more about Accuray Products Continue to Receive Highest Composite User Satisfaction Ratings in Latest MD Buyline Report
Accuray To Report Fiscal 2016 Fourth Quarter And Full Year Results On August 17, 2016 Read more about Accuray To Report Fiscal 2016 Fourth Quarter And Full Year Results On August 17, 2016
Accuray Receives 510(k) FDA Clearance for the Radixact™ Image-Guided Radiation Therapy Platform and Integrated Software Read more about Accuray Receives 510(k) FDA Clearance for the Radixact™ Image-Guided Radiation Therapy Platform and Integrated Software
FUCAM Treats 1,000 Breast Cancer Patients with the TomoTherapy® System Read more about FUCAM Treats 1,000 Breast Cancer Patients with the TomoTherapy® System
United Kingdom's NHS Supply Chain to Acquire Seven TomoTherapy® Systems Read more about United Kingdom's NHS Supply Chain to Acquire Seven TomoTherapy® Systems
Accuray to Participate in the 2016 Jefferies Healthcare Conference Read more about Accuray to Participate in the 2016 Jefferies Healthcare Conference
Accuray to Host Analyst and Investor Day on May 20, 2016 Read more about Accuray to Host Analyst and Investor Day on May 20, 2016
Accuray Signs Long-Term Strategic Development and Supply Agreement with medPhoton for Volumetric Image Guidance Solutions for the CyberKnife® System Read more about Accuray Signs Long-Term Strategic Development and Supply Agreement with medPhoton for Volumetric Image Guidance Solutions for the CyberKnife® System
